SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-038693
Filing Date
2013-05-08
Accepted
2013-05-08 12:03:30
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a13-8037_110q.htm 10-Q 768860
2 EX-31.1 a13-8037_1ex31d1.htm EX-31.1 11407
3 EX-31.2 a13-8037_1ex31d2.htm EX-31.2 11149
4 EX-32.1 a13-8037_1ex32d1.htm EX-32.1 4087
5 EX-32.2 a13-8037_1ex32d2.htm EX-32.2 4079
  Complete submission text file 0001104659-13-038693.txt   7392833

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pcrx-20130331.xml EX-101.INS 845153
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20130331.xsd EX-101.SCH 95105
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20130331_cal.xml EX-101.CAL 75021
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT pcrx-20130331_lab.xml EX-101.LAB 1462139
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20130331_pre.xml EX-101.PRE 624524
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20130331_def.xml EX-101.DEF 347869
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 13823445
SIC: 2834 Pharmaceutical Preparations